摘要
目的就我院2011年至2012年对口服降血糖药的用药情况进行分析,旨在找出其临床用药的某些特点和发展趋势,并探讨降血糖药物的合理选用。方法对我院口服抗糖尿病药物的品种、用药总金额、用药频度、限定日费用等进行统计和分析。结果门诊口服抗糖尿病药使用金额排在前三位的分别是非磺酰脲类促胰岛素分泌药瑞格列奈、磺酰脲类格列美脲胶囊和α-葡萄糖苷酶抑制剂阿卡波糖,其中第二位的格列美脲用药频度上升较大,使用量从2011年的6034合到2012年的13445合,年增长率55.12%。结论我院门诊治疗糖尿病的口服药物共有5类12种(包括一品两规的3种),品种齐全,能够满足临床的需求,在2型糖尿病治疗中应用合理,需求量逐年增加。安全、有效、依从性好、价格适中是糖尿病治疗药物发展的必然趋势。
Objective Our hospital from 2011 to 2012 the drug use of oral hypoglycemic agents analysis aims to identify some of the characteristics of the clinical use of drugs and trends, and to explore the rational use of hypoglycemic agents. Method The varieties of our hospital oral anti-diabetic drugs, the total amount of the medication, medication frequency, defined daily cost statistics and analysis. Results The the outpatient oral anti-diabetic drug use amount of top three are non-sulfonylurea insulin secretion drug repaglinide, the sulfonylurea glimepiride urea capsules and a-glucosidase inhibitor acarbose sugar, the second glimepiride DDDs larger increase in usage from 2011 6034 to 2012 of 13445 Hopewell, with an annual growth rate of 55.12%. Conclusion Our hospital treatment of diabetes oral medication a total of 12 species（including a product of two rules 3）, the full range, to meet the needs of clinical application in the treatment of type 2 diabetes in reasonable demand has increased year by year. Safe, effective, good compliance, affordable is the inevitable trend of the diabetes drug development.
出处
《中国医药指南》
2013年第32期301-304,共4页
Guide of China Medicine
